background	background	NN	B-NP
plasma	plasma	NN	I-NP
membrane	membrane	NN	I-NP
microparticle	microparticle	NN	I-NP
(	(	-LRB-	0
MP	MP	NNP	B-NP
)	)	-RRB-	0
of	of	IN	0
endothelial	endothelial	JJ	B-NP
origin	origin	NN	I-NP
have	have	VBP	0
been	been	VBN	0
identified	identified	VBN	0
in	in	IN	0
normal	normal	JJ	B-NP
human	human	JJ	I-NP
blood	blood	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
3	3	CD	0
]	]	-RRB-	0
and	and	CC	0
increased	increased	JJ	0
counts	counts	NNS	0
of	of	IN	0
microparticle	microparticle	NN	B-NP
carrying	carrying	VBG	0
endothelial	endothelial	JJ	B-NP
antigen	antigen	NN	I-NP
were	were	VBD	0
documented	documented	VBN	0
in	in	IN	0
the	the	DT	0
blood	blood	NN	0
of	of	IN	0
patients	patients	NNS	0
with	with	IN	0
lupus	lupus	JJ	B-NP
anticoagulant	anticoagulant	NN	I-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
,	,	,	0
acute	acute	JJ	0
coronary	coronary	JJ	B-NP
syndrome	syndrome	NN	I-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
,	,	,	0
thrombotic	thrombotic	NN	B-NP
thrombocytopenic	thrombocytopenic	NN	I-NP
purpura	purpura	NNP	I-NP
[	[	-LRB-	0
5	5	LS	0
]	]	-RRB-	0
or	or	CC	0
in	in	IN	0
patients	patients	NNS	0
with	with	IN	0
exacerbated	exacerbated	JJ	0
multiple	multiple	JJ	0
sclerosis	sclerosis	NNS	0
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
Similarly	Similarly	RB	0
to	to	TO	0
blood	blood	NN	B-NP
platelet	platelet	NN	I-NP
,	,	,	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
release	release	VBP	0
microparticle	microparticle	NN	B-NP
which	which	WDT	0
express	express	VBP	0
phosphatidylserina	phosphatidylserina	NN	B-NP
(	(	-LRB-	0
PS	PS	NNP	B-NP
)	)	-RRB-	0
on	on	IN	0
their	their	PRP$	0
surface	surface	NN	0
.	.	.	0
PS-exposing	PS-exposing	NNP	B-NP
MP	MP	NNP	I-NP
in	in	IN	0
blood	blood	NN	0
appear	appear	VBP	0
to	to	TO	0
act	act	VB	0
as	as	IN	0
the	the	DT	0
catalytic	catalytic	JJ	B-NP
surface	surface	NN	I-NP
for	for	IN	0
assembly	assembly	NN	0
of	of	IN	0
the	the	DT	0
prothrombinase	prothrombinase	JJ	B-NP
complex	complex	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
circulating	circulating	VBG	B-NP
MP	MP	NNP	I-NP
of	of	IN	0
various	various	JJ	0
cellular	cellular	JJ	B-NP
origin	origin	NN	I-NP
in	in	IN	0
patient	patient	NN	0
with	with	IN	0
sepsis	sepsis	NN	0
were	were	VBD	0
reported	reported	VBN	0
to	to	TO	0
be	be	VB	0
procoagulant	procoagulant	VBN	0
through	through	IN	0
multiple	multiple	JJ	0
mechanisms	mechanisms	NNS	0
[	[	-LRB-	0
8	8	CD	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
in	in	IN	0
healthy	healthy	JJ	0
individuals	individuals	NNS	0
they	they	PRP	0
may	may	MD	0
have	have	VB	0
an	an	DT	0
anticoagulant	anticoagulant	JJ	B-NP
function	function	NN	I-NP
by	by	IN	0
promoting	promoting	VBG	0
the	the	DT	0
generation	generation	NN	0
of	of	IN	0
low	low	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
thrombin	thrombin	NN	B-NP
that	that	IN	0
activate	activate	JJ	0
protein	protein	NN	B-NP
C	C	NNP	I-NP
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
process	process	NN	0
of	of	IN	0
membrane	membrane	JJ	B-NP
vesiculation	vesiculation	NN	I-NP
and	and	CC	0
MP-release	MP-release	JJ	B-NP
in	in	IN	0
platelet	platelet	NN	B-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
require	require	VB	0
a	a	DT	0
calpain-dependent	calpain-dependent	JJ	B-NP
dissociation	dissociation	NN	I-NP
of	of	IN	0
membrane	membrane	JJ	0
proteins	proteins	NNS	0
from	from	IN	0
the	the	DT	0
submembrane	submembrane	JJ	B-NP
cytoskeleton	cytoskeleton	NN	I-NP
and	and	CC	0
most	most	RBS	0
likely	likely	JJ	0
involves	involves	NNS	0
intracellular	intracellular	VBP	0
signaling	signaling	VBG	0
by	by	IN	0
platelet	platelet	JJ	B-NP
protein	protein	NN	I-NP
kinas	kinas	NNP	I-NP
[	[	-LRB-	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
Besides	Besides	IN	0
platelets	platelets	JJ	B-NP
stimulated	stimulated	NN	I-NP
by	by	IN	0
various	various	JJ	0
agonists	agonists	JJ	0
such	such	JJ	0
as	as	IN	0
thrombin	thrombin	NN	B-NP
with	with	IN	0
collagen	collagen	NN	B-NP
or	or	CC	0
the	the	DT	0
complement	complement	JJ	B-NP
complex	complex	JJ	0
C5b-9	C5b-9	NNP	0
[	[	-LRB-	0
7	7	CD	0
11	11	CD	0
]	]	-RRB-	0
,	,	,	0
a	a	DT	0
release	release	NN	0
of	of	IN	0
PS-containing	PS-containing	JJ	B-NP
membrane	membrane	JJ	I-NP
MP	MP	NNP	I-NP
was	was	VBD	0
demonstrated	demonstrated	VBN	0
in	in	IN	0
other	other	JJ	0
cell	cell	NN	0
types	types	NNS	0
such	such	JJ	0
as	as	IN	0
endotoxin-stimulated	endotoxin-stimulated	JJ	B-NP
monocyte	monocyte	NN	I-NP
[	[	-LRB-	0
12	12	CD	0
]	]	-RRB-	0
,	,	,	0
polymorphonuclear	polymorphonuclear	NNS	B-NP
leucocyte	leucocyte	NN	I-NP
stimulated	stimulated	VBN	0
with	with	IN	0
the	the	DT	0
chemotactic	chemotactic	NN	B-NP
peptide	peptide	NN	I-NP
FMLP	FMLP	NN	I-NP
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
or	or	CC	0
apoptotic	apoptotic	JJ	B-NP
t-lymphocyte	t-lymphocyte	NN	I-NP
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
phosphatidylserine	phosphatidylserine	NN	B-NP
normal	normal	JJ	I-NP
restriction	restriction	NN	I-NP
to	to	TO	0
the	the	DT	0
inner	inner	JJ	0
surface	surface	NN	0
of	of	IN	0
the	the	DT	0
plasma	plasma	JJ	0
membrane	membrane	NN	0
becomes	becomes	VBZ	0
perturbed	perturbed	VBN	0
in	in	IN	0
apoptotic	apoptotic	JJ	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
When	When	WRB	0
exposed	exposed	VBN	0
,	,	,	0
phosphatidylserine	phosphatidylserine	NN	B-NP
is	is	VBZ	0
a	a	DT	0
phagocyte	phagocyte	JJ	B-NP
recognition	recognition	NN	I-NP
determinant	determinant	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
to	to	TO	0
be	be	VB	0
cleared	cleared	VBN	0
.	.	.	0
Plasma	Plasma	JJ	B-NP
membrane	membrane	JJ	I-NP
blebbing	blebbing	NN	I-NP
and	and	CC	0
MP-release	MP-release	NN	B-NP
are	are	VBP	0
generally	generally	RB	0
accepted	accepted	VBN	0
as	as	IN	0
typical	typical	JJ	0
signs	signs	NNS	0
of	of	IN	0
cell	cell	NN	B-NP
apoptosi	apoptosi	NN	I-NP
[	[	-LRB-	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
a	a	DT	0
possible	possible	JJ	0
circulating	circulating	VBG	B-NP
mp	mp	NN	I-NP
pathophysiological	pathophysiological	JJ	I-NP
role	role	NN	I-NP
,	,	,	0
analysis	analysis	NN	0
of	of	IN	0
microparticle	microparticle	NN	B-NP
derived	derived	VBD	0
from	from	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
may	may	MD	0
be	be	VB	0
a	a	DT	0
valuable	valuable	JJ	0
vessel	vessel	JJ	B-NP
wall	wall	NN	I-NP
injury	injury	NN	I-NP
diagnostic	diagnostic	JJ	I-NP
marker	marker	NN	I-NP
.	.	.	0
The	The	DT	0
phospholipid-binding	phospholipid-binding	JJ	B-NP
protein	protein	NN	I-NP
annexin	annexin	VBD	0
V	V	NNP	0
has	has	VBZ	0
a	a	DT	0
high	high	JJ	0
phosphatidylserine	phosphatidylserine	NN	B-NP
affinity	affinity	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
and	and	CC	0
is	is	VBZ	0
utilized	utilized	VBN	0
in	in	IN	0
MP	MP	NNP	B-NP
detection	detection	NN	I-NP
in	in	IN	0
blood	blood	NN	0
and	and	CC	0
in	in	IN	0
cell	cell	NN	B-NP
supernatant	supernatant	NN	I-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
Since	Since	IN	0
very	very	RB	0
little	little	RB	0
is	is	VBZ	0
known	known	VBN	0
about	about	IN	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
MP-release	MP-release	JJ	B-NP
from	from	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
difficult	difficult	JJ	0
to	to	TO	0
judge	judge	VB	0
the	the	DT	0
type	type	NN	0
and	and	CC	0
extent	extent	NN	0
of	of	IN	0
endothelial	endothelial	JJ	B-NP
injury	injury	NN	I-NP
represented	represented	VBD	0
by	by	IN	0
increased	increased	JJ	0
endothelial	endothelial	JJ	B-NP
mp	mp	NN	I-NP
plasma	plasma	NN	I-NP
count	count	NN	I-NP
.	.	.	0
We	We	PRP	0
used	used	VBD	0
flow	flow	NN	B-NP
cytometry	cytometry	NN	I-NP
to	to	TO	0
study	study	VB	0
the	the	DT	0
release	release	NN	0
of	of	IN	0
annexin	annexin	NN	B-NP
V-binding	V-binding	FW	0
membrane	membrane	NN	B-NP
microparticle	microparticle	NN	I-NP
from	from	FW	0
cultured	cultured	FW	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
HUVEC	HUVEC	NNP	B-NP
)	)	-RRB-	0
stimulated	stimulated	VBN	0
by	by	IN	0
various	various	JJ	0
agonist	agonist	NN	B-NP
.	.	.	0
We	We	PRP	0
further	further	RB	0
focused	focused	VBN	0
our	our	PRP$	0
study	study	NN	0
on	on	IN	0
MP-release	MP-release	JJ	B-NP
from	from	IN	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
after	after	IN	0
proapoptotic	proapoptotic	JJ	B-NP
stimulation	stimulation	NN	I-NP
with	with	IN	0
the	the	DT	0
inhibitor	inhibitor	VBP	B-NP
camptothecin	camptothecin	NNS	I-NP
topoisomerase	topoisomerase	NN	I-NP
i	i	NN	I-NP
(	(	-LRB-	0
CPT	CPT	NNP	0
)	)	-RRB-	0
.	.	.	0
Since	Since	IN	0
cpt	cpt	NN	B-NP
analogue	analogue	NN	I-NP
become	become	VBN	0
one	one	CD	0
of	of	IN	0
the	the	DT	0
most	most	RBS	0
promising	promising	JJ	0
new	new	JJ	0
classes	classes	NNS	0
of	of	IN	0
antineoplastic	antineoplastic	JJ	B-NP
agent	agent	NN	I-NP
introduced	introduced	VBN	0
into	into	IN	0
the	the	DT	0
clinic	clinic	NN	0
in	in	IN	0
recent	recent	JJ	0
years	years	NNS	0
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
,	,	,	0
activity	activity	NN	0
of	of	IN	0
camptothecin	camptothecin	NN	B-NP
on	on	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
may	may	MD	0
be	be	VB	0
of	of	IN	0
great	great	JJ	0
interest	interest	NN	0
.	.	.	0
Results	Results	NNS	0
With	With	IN	0
the	the	DT	0
exception	exception	NN	0
of	of	IN	0
high	high	JJ	0
ionophore	ionophore	CD	B-NP
concentration	concentration	NN	I-NP
A23187	A23187	CD	0
,	,	,	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
rapid	rapid	JJ	I-NP
stimulation	stimulation	NN	I-NP
with	with	IN	0
various	various	JJ	0
agonist	agonist	NN	B-NP
did	did	VBD	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
a	a	DT	0
release	release	NN	0
of	of	IN	0
annexin	annexin	NN	B-NP
V-binding	V-binding	FW	0
flow	flow	NN	B-NP
cytometry	cytometry	NN	I-NP
analysis	analysis	NN	I-NP
microparticle	microparticle	NN	I-NP
of	of	IN	0
HUVEC	HUVEC	NNP	B-NP
culture	culture	NN	I-NP
supernatant	supernatant	VBZ	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
a	a	DT	0
30	30	CD	0
min	min	JJ	B-NP
treatment	treatment	NN	I-NP
with	with	IN	0
10	10	CD	0
μM	μM	JJ	B-NP
ionophora	ionophora	NN	I-NP
A23187	A23187	VBP	0
caused	caused	VBN	0
the	the	DT	0
release	release	NN	0
of	of	IN	0
low	low	JJ	0
counts	counts	NNS	0
of	of	IN	0
annexin	annexin	JJ	B-NP
V-binding	V-binding	JJ	I-NP
MP	MP	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
)	)	-RRB-	0
.	.	.	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
similar	similar	JJ	I-NP
short-time	short-time	JJ	I-NP
activation	activation	NN	I-NP
with	with	IN	0
phorbol	phorbol	NN	B-NP
myristate	myristate	NN	I-NP
acetate	acetate	NN	I-NP
(	(	-LRB-	0
PMA	PMA	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
1	1	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
mL	mL	NN	I-NP
)	)	-RRB-	0
,	,	,	0
human	human	JJ	0
activating	activating	VBG	B-NP
peptide	peptide	NN	I-NP
thrombin	thrombin	NN	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
TRAP	TRAP	NNP	B-NP
)	)	-RRB-	0
1-50	1-50	FW	0
μmol	μmol	NN	B-NP
/	/	NN	I-NP
L	L	NNP	I-NP
,	,	,	0
human	human	JJ	0
thrombin	thrombin	NN	B-NP
(	(	-LRB-	0
THR	THR	NNP	B-NP
)	)	-RRB-	0
0.1-10	0.1-10	NNP	0
NIH	NIH	NNP	B-NP
Unit	Unit	NNP	0
/	/	NNP	0
mL	mL	NNP	0
,	,	,	0
human	human	JJ	0
tissue	tissue	NN	B-NP
plasminogen	plasminogen	NN	I-NP
activator	activator	NN	I-NP
(	(	-LRB-	0
TPA	TPA	NNP	B-NP
)	)	-RRB-	0
3.5	3.5	CD	0
kU	kU	JJ	0
/	/	NNP	0
mL	mL	NNP	0
or	or	CC	0
human	human	JJ	0
angiotensin	angiotensin	JJ	B-NP
II	II	NNP	I-NP
(	(	-LRB-	0
AGTII	AGTII	NNP	B-NP
)	)	-RRB-	0
1	1	CD	0
μmol	μmol	CD	B-NP
/	/	CD	I-NP
L	L	NNP	I-NP
did	did	VBD	0
not	not	RB	0
cause	cause	VB	0
any	any	DT	0
significant	significant	JJ	0
increase	increase	NN	0
in	in	IN	0
MP-release	MP-release	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
of	of	IN	0
the	the	DT	0
agonist	agonist	NN	B-NP
applied	applied	VBD	0
induced	induced	VBN	0
morphological	morphological	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
seen	seen	VBN	0
by	by	IN	0
phase	phase	NN	0
contrast	contrast	NN	0
light	light	NN	0
microscopy	microscopy	NN	0
,	,	,	0
which	which	WDT	0
confirmed	confirmed	VBD	0
the	the	DT	0
cellular	cellular	JJ	B-NP
activation	activation	NN	I-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Proapoptotic	Proapoptotic	NNP	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
proinflammatory	proinflammatory	JJ	0
,	,	,	0
stimulation	stimulation	VBD	0
induced	induced	VBN	0
a	a	DT	0
release	release	NN	0
of	of	IN	0
annexin	annexin	JJ	B-NP
v-binding	v-binding	NN	I-NP
microparticle	microparticle	NN	I-NP
from	from	IN	0
HUVEC	HUVEC	NNP	B-NP
MP	MP	NNP	I-NP
count	count	NN	I-NP
increased	increased	VBD	0
overnight	overnight	JJ	0
in	in	IN	0
the	the	DT	0
media	media	NNS	0
of	of	IN	0
unstimulated	unstimulated	JJ	B-NP
cell	cell	NN	I-NP
culture	culture	NN	I-NP
,	,	,	0
but	but	CC	0
this	this	DT	0
was	was	VBD	0
not	not	RB	0
enhanced	enhanced	VBN	0
by	by	IN	0
TNFα	TNFα	NNP	B-NP
(	(	-LRB-	0
1000	1000	CD	0
U	U	NNP	0
/	/	NNP	0
mL	mL	NNP	0
)	)	-RRB-	0
or	or	CC	0
by	by	IN	0
lipopolysaccharide	lipopolysaccharide	NN	B-NP
(	(	-LRB-	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
mL	mL	NN	I-NP
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
when	when	WRB	0
cells	cells	NNS	0
were	were	VBD	0
activated	activated	VBN	0
with	with	IN	0
TNFα	TNFα	JJ	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
cycloheximida	cycloheximida	NN	B-NP
(	(	-LRB-	0
50	50	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
mL	mL	NN	I-NP
)	)	-RRB-	0
to	to	TO	0
promote	promote	VB	0
apoptosi	apoptosi	NN	B-NP
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
,	,	,	0
a	a	DT	0
dramatic	dramatic	JJ	0
increase	increase	NN	0
in	in	IN	0
MP	MP	NNP	B-NP
count	count	NN	I-NP
was	was	VBD	0
observed	observed	VBN	0
,	,	,	0
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
TNFα	TNFα	JJ	0
or	or	CC	0
cycloheximide	cycloheximide	JJ	B-NP
treatment	treatment	NN	I-NP
alone	alone	RB	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
apoptosi	apoptosi	NN	B-NP
induction	induction	VBG	I-NP
with	with	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
CPT	CPT	NNP	I-NP
,	,	,	0
a	a	DT	0
topoisomerase	topoisomerase	NN	B-NP
I	I	PRP	I-NP
inhibitor	inhibitor	VBP	0
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
,	,	,	0
led	led	VBN	0
to	to	TO	0
a	a	DT	0
release	release	NN	0
of	of	IN	0
annexin	annexin	JJ	B-NP
V-binding	V-binding	JJ	I-NP
MP	MP	NNP	I-NP
which	which	WDT	0
was	was	VBD	0
prevented	prevented	VBN	0
by	by	IN	0
ZVAD	ZVAD	NNP	B-NP
.	.	.	0
ZVAD	ZVAD	NNP	B-NP
also	also	RB	0
inhibited	inhibited	VBD	0
a	a	DT	0
release	release	NN	0
of	of	IN	0
microparticle	microparticle	NN	B-NP
from	from	IN	0
unstimulated	unstimulated	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
which	which	WDT	0
probably	probably	RB	0
represents	represents	VBZ	0
spontaneous	spontaneous	JJ	B-NP
apoptosi	apoptosi	NN	I-NP
of	of	IN	0
cultured	cultured	JJ	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
.	.	.	0
MP-release	MP-release	NNP	B-NP
did	did	VBD	0
not	not	RB	0
correlate	correlate	VBN	0
with	with	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
cell	cell	NN	B-NP
apoptosi	apoptosi	NN	I-NP
in	in	IN	0
HUVEC	HUVEC	NNP	B-NP
stimulated	stimulated	NN	I-NP
with	with	IN	0
camptothecin	camptothecin	JJ	B-NP
Phase	Phase	NN	I-NP
contrast	contrast	NN	I-NP
microscopy	microscopy	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
HUVEC	HUVEC	NNP	B-NP
culture	culture	NN	I-NP
treated	treated	VBN	0
for	for	IN	0
24	24	CD	0
hr	hr	NN	B-NP
with	with	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
CPT	CPT	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2C	2C	NNP	0
)	)	-RRB-	0
lost	lost	VBD	0
confluence	confluence	VBN	B-NP
with	with	IN	0
about	about	IN	0
30-40	30-40	CD	0
%	%	NN	0
cells	cells	NNS	0
remaining	remaining	VBG	B-NP
adherent	adherent	NN	I-NP
.	.	.	0
The	The	DT	0
level	level	NN	0
of	of	IN	0
adherent	adherent	JJ	B-NP
cell	cell	NN	I-NP
apoptosi	apoptosi	NN	I-NP
was	was	VBD	0
assessed	assessed	VBN	0
by	by	IN	0
using	using	VBG	0
TUNEL	TUNEL	NNP	B-NP
and	and	CC	0
annexin	annexin	NN	B-NP
V-FITC	V-FITC	NN	I-NP
/	/	FW	0
propidium	propidium	NN	B-NP
iodide	iodide	NN	I-NP
assay	assay	NN	I-NP
(	(	-LRB-	0
Fig	Fig	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
Approximately	Approximately	RB	0
one	one	CD	0
third	third	JJ	0
of	of	IN	0
the	the	DT	0
remaining	remaining	JJ	0
adherent	adherent	JJ	B-NP
cell	cell	NN	I-NP
showed	showed	VBD	0
annexin	annexin	JJ	B-NP
V-binding	V-binding	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3B	3B	NNP	0
)	)	-RRB-	0
and	and	CC	0
DNA-fragmentation	DNA-fragmentation	NNP	B-NP
(	(	-LRB-	0
TUNEL-positivity	TUNEL-positivity	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3C	3C	NNP	0
)	)	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
a	a	DT	0
ten	ten	JJ	0
times	times	NNS	0
lower	lower	JJR	0
cpt	cpt	NN	B-NP
concentration	concentration	NN	I-NP
(	(	-LRB-	0
500	500	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
also	also	RB	0
induced	induced	VBN	0
significant	significant	JJ	0
MP-release	MP-release	NN	B-NP
after	after	IN	0
only	only	RB	0
4	4	CD	0
hr	hr	NN	B-NP
of	of	IN	0
treatment	treatment	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
and	and	CC	0
after	after	IN	0
24	24	CD	0
hr	hr	NN	B-NP
,	,	,	0
500	500	CD	0
induced	induced	VBP	B-NP
mp-release	mp-release	NN	I-NP
nm	nm	NN	I-NP
camptothecin	camptothecin	NNS	I-NP
comparable	comparable	JJ	0
to	to	TO	0
5	5	CD	0
μM	μM	JJ	B-NP
CPT	CPT	NNP	I-NP
treatment	treatment	NN	I-NP
,	,	,	0
but	but	CC	0
without	without	IN	0
any	any	DT	0
significant	significant	JJ	0
increase	increase	NN	0
in	in	IN	0
annexin	annexin	JJ	B-NP
V-binding	V-binding	JJ	I-NP
to	to	TO	0
the	the	DT	0
cells	cells	NNS	0
or	or	CC	0
DNA-fragmentation	DNA-fragmentation	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3B	3B	NNP	0
,	,	,	0
3C	3C	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
cell	cell	NN	0
culture	culture	NN	0
was	was	VBD	0
still	still	RB	0
confluent	confluent	JJ	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2B	2B	NNP	0
)	)	-RRB-	0
with	with	IN	0
about	about	IN	0
20-30	20-30	CD	0
%	%	NN	0
lower	lower	JJR	0
cell	cell	NN	0
density	density	VBZ	0
as	as	RB	0
compared	compared	VBN	0
with	with	IN	0
0.5	0.5	CD	0
%	%	NN	0
treated	treated	VBD	B-NP
huvec	huvec	NN	I-NP
dmso	dmso	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
result	result	NN	0
indicates	indicates	VBZ	0
that	that	IN	0
MP-release	MP-release	NNP	B-NP
is	is	VBZ	0
not	not	RB	0
related	related	VBN	0
to	to	TO	0
cell	cell	NN	B-NP
desquamation	desquamation	NN	I-NP
.	.	.	0
To	To	TO	0
investigate	investigate	VB	0
whether	whether	IN	0
maturation	maturation	NN	B-NP
of	of	IN	0
the	the	DT	0
cell	cell	NN	0
culture	culture	NN	0
influences	influences	VBZ	0
the	the	DT	0
degree	degree	NN	0
of	of	IN	0
MP-release	MP-release	JJ	B-NP
from	from	IN	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
CPT	CPT	NNP	B-NP
,	,	,	0
we	we	PRP	0
compared	compared	VBD	0
MP-release	MP-release	JJ	B-NP
from	from	IN	0
subconfluent	subconfluent	JJ	B-NP
HUVEC	HUVEC	NNP	I-NP
(	(	-LRB-	0
50	50	CD	0
%	%	NN	0
of	of	IN	0
confluence	confluence	CD	B-NP
)	)	-RRB-	0
at	at	IN	0
24	24	CD	0
hr	hr	NN	B-NP
in	in	IN	0
culture	culture	NN	0
,	,	,	0
reaching	reaching	VBG	B-NP
confluence	confluence	NN	I-NP
human	human	JJ	I-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
at	at	IN	0
48	48	CD	0
hr	hr	NN	B-NP
in	in	IN	0
culture	culture	NN	0
and	and	CC	0
overgrown	overgrown	JJ	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
at	at	IN	0
72	72	CD	0
hr	hr	NN	B-NP
in	in	IN	0
culture	culture	NN	0
.	.	.	0
Our	Our	PRP$	0
results	results	NNS	0
showed	showed	VBD	0
that	that	DT	0
MP-release	MP-release	JJ	B-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
CPT	CPT	NNP	B-NP
declined	declined	VBD	0
with	with	IN	0
culture	culture	NN	B-NP
maturation	maturation	NN	I-NP
.	.	.	0
There	There	EX	0
was	was	VBD	0
also	also	RB	0
a	a	DT	0
change	change	NN	0
of	of	IN	0
the	the	DT	0
sensitivity	sensitivity	NN	0
of	of	IN	0
overgrown	overgrown	JJ	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
to	to	TO	0
CPT	CPT	NNP	B-NP
treatment	treatment	NN	I-NP
in	in	IN	0
confluent	confluent	CD	0
72	72	CD	0
hr	hr	NN	B-NP
old	old	JJ	0
culture	culture	NN	0
resulting	resulting	VBG	0
in	in	IN	0
the	the	DT	0
higher	higher	JJR	0
cpt	cpt	NN	B-NP
concentration	concentration	NN	I-NP
(	(	-LRB-	0
5	5	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
releasing	releasing	VBG	0
higher	higher	JJR	0
levels	levels	NNS	0
of	of	IN	0
microparticle	microparticle	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
growing	growing	VBG	0
culture	culture	NN	0
at	at	IN	0
24	24	CD	0
hr	hr	NN	B-NP
,	,	,	0
500	500	CD	0
nM	nM	JJ	B-NP
CPT	CPT	NNP	I-NP
caused	caused	VBD	0
even	even	RB	0
higher	higher	JJR	0
MP-release	MP-release	NN	B-NP
than	than	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
CPT	CPT	NNP	I-NP
.	.	.	0
In	In	IN	0
confluent	confluent	JJ	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
48	48	CD	0
hr	hr	NN	B-NP
old	old	JJ	0
,	,	,	0
the	the	DT	0
MP-release	MP-release	JJ	B-NP
induced	induced	NN	I-NP
by	by	IN	0
500	500	CD	0
nM	nM	JJ	0
and	and	CC	0
5	5	CD	0
μM	μM	JJ	B-NP
CPT	CPT	NNP	I-NP
was	was	VBD	0
not	not	RB	0
significantly	significantly	RB	0
different	different	JJ	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
endothelial	endothelial	NN	B-NP
antigen	antigen	NN	I-NP
CD	CD	NN	0
105	105	CD	0
and	and	CC	0
CD	CD	NNP	0
59	59	CD	0
were	were	VBD	0
both	both	DT	0
expressed	expressed	VBN	0
on	on	IN	0
living	living	VBG	B-NP
cell	cell	NN	I-NP
,	,	,	0
apoptotic	apoptotic	JJ	B-NP
body	body	NN	I-NP
and	and	CC	0
other	other	JJ	0
cell	cell	NN	0
fragments	fragments	NNS	0
in	in	IN	0
treated	treated	VBD	B-NP
huvec	huvec	NN	I-NP
culture	culture	NN	I-NP
cpt	cpt	NN	I-NP
but	but	CC	0
CD	CD	NNP	0
105	105	CD	0
was	was	VBD	0
absent	absent	VBN	0
on	on	IN	0
50	50	CD	0
%	%	NN	0
of	of	IN	0
annexin	annexin	JJ	B-NP
V-binding	V-binding	JJ	I-NP
membrane	membrane	NN	I-NP
microparticles	microparticles	VBP	0
Using	Using	VBG	B-NP
flow	flow	NN	I-NP
cytometry	cytometry	NN	I-NP
,	,	,	0
in	in	IN	0
SSC	SSC	NNP	B-NP
vs.	vs.	FW	0
FSC	FSC	NN	B-NP
plot	plot	FW	0
we	we	FW	0
gated	gated	FW	0
homogeneous	homogeneous	JJ	B-NP
population	population	NN	I-NP
of	of	IN	0
single	single	JJ	0
living	living	NN	0
cells	cells	NNS	0
(	(	-LRB-	0
G1	G1	NNP	0
on	on	IN	0
Fig.	Fig.	CD	0
5A	5A	CD	0
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
appeared	appeared	VBD	0
negative	negative	JJ	0
in	in	IN	0
propidium	propidium	NN	B-NP
iodide	iodide	NN	I-NP
staining	staining	FW	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
living	living	JJ	B-NP
cell	cell	NN	I-NP
from	from	IN	0
control	control	NN	B-NP
culture	culture	NN	I-NP
as	as	IN	0
well	well	RB	0
as	as	RB	0
from	from	IN	0
cultures	cultures	NNS	0
treated	treated	VBN	0
with	with	IN	0
CPT	CPT	NNP	B-NP
were	were	VBD	0
strongly	strongly	RB	0
positive	positive	JJ	0
for	for	IN	0
both	both	DT	0
antigens	antigens	JJ	0
CD	CD	NN	0
105	105	CD	0
and	and	CC	0
CD	CD	NNP	0
59	59	CD	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5C	5C	NNP	0
)	)	-RRB-	0
.	.	.	0
Expression	Expression	NN	0
of	of	IN	0
CD59	CD59	CD	B-NP
on	on	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
was	was	VBD	0
not	not	RB	0
influenced	influenced	VBN	0
by	by	IN	0
24	24	CD	0
hrs	hrs	JJ	B-NP
incubation	incubation	NN	I-NP
with	with	IN	0
500nM	500nM	NNP	0
or	or	CC	0
5μM	5μM	NNP	B-NP
CPT	CPT	NNP	I-NP
as	as	RB	0
compared	compared	VBN	0
with	with	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
incubated	incubated	VBN	0
with	with	IN	0
0.5	0.5	CD	0
%	%	NN	0
DMSO	DMSO	NNP	B-NP
.	.	.	0
Expression	Expression	NN	0
of	of	IN	0
CD105	CD105	NNP	B-NP
was	was	VBD	0
only	only	RB	0
slightly	slightly	RB	0
decreased	decreased	VBN	0
on	on	IN	0
CPT	CPT	NNP	B-NP
treated	treated	VBD	0
cells	cells	NNS	0
.	.	.	0
Cell	Cell	NN	0
fragments	fragments	VBZ	0
>	>	CD	0
4	4	CD	0
μm	μm	NN	B-NP
in	in	IN	0
size	size	NN	0
as	as	IN	0
compared	compared	VBN	0
with	with	IN	0
standard	standard	JJ	0
beads	beads	NN	0
were	were	VBD	0
gated	gated	VBN	0
separately	separately	RB	0
(	(	-LRB-	0
G2	G2	NNP	0
on	on	IN	0
Fig.	Fig.	CD	0
5A	5A	CD	0
)	)	-RRB-	0
.	.	.	0
Larger	Larger	JJR	0
cell	cell	NN	0
fragments	fragments	NNS	0
appeared	appeared	VBD	0
positive	positive	JJ	0
in	in	IN	0
propidium	propidium	NN	B-NP
iodide	iodide	NN	I-NP
staining	staining	FW	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
analyzed	analyzed	JJ	0
cell	cell	NN	0
fragments	fragments	NNS	0
were	were	VBD	0
positive	positive	JJ	0
for	for	IN	0
CD59	CD59	NNP	B-NP
and	and	CC	0
also	also	RB	0
expressed	expressed	VBD	0
CD	CD	NNP	0
105	105	CD	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5D	5D	NNP	0
)	)	-RRB-	0
.	.	.	0
Comparison	Comparison	NN	0
of	of	IN	0
areas	areas	NNS	0
under	under	IN	0
the	the	DT	0
different	different	JJ	0
peaks	peaks	NNS	0
on	on	IN	0
the	the	DT	0
histogram	histogram	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5C	5C	NNP	0
,	,	,	0
5D	5D	CD	0
)	)	-RRB-	0
indicates	indicates	VBZ	0
that	that	IN	0
the	the	DT	0
portion	portion	NN	0
of	of	IN	0
cell	cell	NN	0
fragments	fragments	VBZ	0
corresponding	corresponding	JJ	0
to	to	TO	0
apoptotic	apoptotic	VB	0
bodies	bodies	NNS	0
and	and	CC	0
necrotic	necrotic	JJ	B-NP
cell	cell	NN	I-NP
was	was	VBD	0
significantly	significantly	RB	0
higher	higher	JJR	0
in	in	IN	0
culture	culture	NN	0
treated	treated	VBN	0
with	with	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
CPT	CPT	NNP	I-NP
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
culture	culture	VB	0
treated	treated	VBN	0
with	with	IN	0
500	500	CD	0
nM	nM	JJ	B-NP
CPT	CPT	NNP	I-NP
or	or	CC	0
with	with	IN	0
0.5	0.5	CD	0
%	%	NN	0
DMSO	DMSO	NNP	B-NP
alone	alone	RB	0
.	.	.	0
In	In	IN	0
a	a	DT	0
separate	separate	JJ	0
protocol	protocol	NN	0
we	we	PRP	0
analyzed	analyzed	VBD	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
CD	CD	NNP	0
59	59	CD	0
and	and	CC	0
CD	CD	NNP	0
105	105	CD	0
on	on	IN	0
membrane	membrane	JJ	B-NP
MP	MP	NNP	I-NP
.	.	.	0
Comparison	Comparison	NN	0
of	of	IN	0
FSC	FSC	NNP	B-NP
values	values	NNS	0
of	of	IN	0
standard	standard	JJ	0
beads	beads	NN	0
and	and	CC	0
analyzed	analyzed	VBD	B-NP
MP	MP	NNP	I-NP
showed	showed	VBD	0
that	that	IN	0
95	95	CD	0
%	%	NN	0
of	of	IN	0
annexin	annexin	JJ	B-NP
V-binding	V-binding	JJ	I-NP
MP	MP	NNP	I-NP
released	released	VBD	0
from	from	IN	0
human	human	JJ	B-NP
umbilical	umbilical	JJ	I-NP
vein	vein	NN	I-NP
endothelial	endothelial	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
